Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Videos

Dr Thomas Zeller
AMP 2024
SPORTS: Drug-Eluting Stent or Primary Bare Nitinol Stent Application vs Drug-Coated Balloons in Long SFA Lesions; HEAL Study Update
09/18/2024
In this video, Dr. Thomas Zeller discusses the latest results from the SPORTS trial and the HEAL study.
In this video, Dr. Thomas Zeller discusses the latest results from the SPORTS trial and the HEAL study.
In this video, Dr. Thomas Zeller...
09/18/2024
Vascular Disease Management
Dr. Michael Siah
AMP 2024
ZilverPASS 5-year Results; Deep Vein Arterialization: History and Rationale
09/17/2024
Watch as Dr. Michael Siah discusses 2 of his AMP 2024 presentations on ZilverPASS and DVA.
Watch as Dr. Michael Siah discusses 2 of his AMP 2024 presentations on ZilverPASS and DVA.
Watch as Dr. Michael Siah...
09/17/2024
Vascular Disease Management

Advertisement

Zola N'Dandu, MD
AMP 2024
Pooled Analysis of the DETOUR System; Risk Factors in CLI Patients That May Require DVA
09/17/2024
In this video, Dr. Zola N'Dandu discusses two of his AMP 2024 presentations.
In this video, Dr. Zola N'Dandu discusses two of his AMP 2024 presentations.
In this video, Dr. Zola N'Dandu...
09/17/2024
Vascular Disease Management
Mary Yost
AMP 2024
What Is the Impact of Amputation as a Treatment for CLI? Economic Costs and Patient Consequences
09/16/2024
Watch as Mary Yost, MBA, cofounder of The Yost Group, discusses her AMP 2024 presentation on the consequences of amputation as a treatment for patients with critical limb ischemia.
Watch as Mary Yost, MBA, cofounder of The Yost Group, discusses her AMP 2024 presentation on the consequences of amputation as a treatment for patients with critical limb ischemia.
Watch as Mary Yost, MBA,...
09/16/2024
Vascular Disease Management
Dr Thomas Davis
AMP 2024
CLI Subgroup Analysis From the US SAFE-DCB Registry: Final 3-year Follow-up Results
09/12/2024
In this video recorded at AMP 2024, Dr. Thomas Davis discusses his presentation on the SAFE-DCB registry, a prospective, multicenter, single-arm, real-world US registry assessing the Lutonix 035 drug-coated balloon.
In this video recorded at AMP 2024, Dr. Thomas Davis discusses his presentation on the SAFE-DCB registry, a prospective, multicenter, single-arm, real-world US registry assessing the Lutonix 035 drug-coated balloon.
In this video recorded at AMP...
09/12/2024
Vascular Disease Management

Advertisement

Dr Marianne Brodmann
AMP 2024
Experience of a Laser and Optics-based Peripheral Intravascular Lithotripsy System for the Treatment of Above-the-Knee Calcified Lesions
09/12/2024
Watch as Dr. Marianne Brodmann discusses her AMP 2024 presentation on IVL for treatinng above-the-knee calcified lesions.
Watch as Dr. Marianne Brodmann discusses her AMP 2024 presentation on IVL for treatinng above-the-knee calcified lesions.
Watch as Dr. Marianne Brodmann...
09/12/2024
Vascular Disease Management
Dr Constantino Pena
AMP 2024
High Limb Salvage Rate and Improved Quality of Life Following Aspiration Thrombectomy With Indigo for Lower-Extremity Acute Limb Ischemia
09/11/2024
Watch as Dr. Constantino Peña discusses his AMP presentation on the 12-month results from the STRIDE study.
Watch as Dr. Constantino Peña discusses his AMP presentation on the 12-month results from the STRIDE study.
Watch as Dr. Constantino Peña...
09/11/2024
Vascular Disease Management
Dr Eric Secemsky
AMP 2024
Variation in Revascularization Strategies for CLTI: A Nationwide Analysis of Medicare Beneficiaries
09/11/2024
In this video recorded at AMP 2024, interventional cardiologist Dr. Eric Secemsky discusses a recent analysis of Medicare beneficiaries undergoing endovascular treatment for CLTI in both high- and low-volume facilities.
In this video recorded at AMP 2024, interventional cardiologist Dr. Eric Secemsky discusses a recent analysis of Medicare beneficiaries undergoing endovascular treatment for CLTI in both high- and low-volume facilities.
In this video recorded at AMP...
09/11/2024
Vascular Disease Management

Advertisement

Dr Barry Katzen
AMP 2024
The CLI Global Society: Why Is Membership Important?
09/10/2024
Watch as Dr. Barry Katzen, president and founding board member of the CLI Global Society, discusses the importance of membership in the Society.
Watch as Dr. Barry Katzen, president and founding board member of the CLI Global Society, discusses the importance of membership in the Society.
Watch as Dr. Barry Katzen,...
09/10/2024
Vascular Disease Management
John Rundback MD
AMP 2024
Auryon Laser for the Treatment of Diabetic Patients: A Subgroup Analysis of the PATHFINDER Registry
09/10/2024
Watch as John Rundback, MD, from Advanced Interventional & Vascular Services in New Jersey, discusses his presentation on the PATHFINDER Registry at AMP 2024.
Watch as John Rundback, MD, from Advanced Interventional & Vascular Services in New Jersey, discusses his presentation on the PATHFINDER Registry at AMP 2024.
Watch as John Rundback, MD, from...
09/10/2024
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

News
Double Win With Bridging Stents: FEVAR Certifications for BeGraft and BeFlared
11/20/2024
Hechingen, November 20th, 2024. With two certificates granted by TÜV, Bentley achieved another break-through in extending indications for its stents in complex aortic interventions. Thanks to one certificate, the Bentley BeGraft stent now is...
Hechingen, November 20th, 2024. With two certificates granted by TÜV, Bentley achieved another break-through in extending indications for its stents in complex aortic interventions. Thanks to one certificate, the Bentley BeGraft stent now is...
Hechingen, November 20th, 2024....
11/20/2024
Vascular Disease Management
First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use